Who should take EyePromise AREDS 2 Plus Multi-Vitamin?
EyePromise AREDS 2 Plus Multi-Vitamin is designed for people with intermediate
to advanced age-related eye health issues. What is the Age-Related Eye Disease
Study 2 (AREDS 2)? The Age-Related Eye Disease Study 2 (AREDS 2) is a five-
year, multi-center, randomized trial designed to assess the effects of oral
supplementation on the progression to advanced age-related macular
degeneration (AMD) in patients at high risk for developing advanced AMD. Is it
true that subjects in the AREDS study also took a multi-vitamin? Yes. In the
original AREDS study, approximately 67% of the participants took a multi
vitamin while nearly 90% of AREDS 2 participants took a multi-vitamin. What
were the results of the AREDS 2 study? 1. Supplementing with the AREDS 2
formula resulted in a 10% incremental slowing of progression to advanced Age-
Related Macular Degeneration 2. The reduction in progression to advanced Age-
Related Macular Degeneration is even greater (26%) in study subjects with the
lowest intake of Zeaxanthin and Lutein in their diet, which is more
representative of the general U.S. population where the dietary intake of
Zeaxanthin and Lutein is typically less than 1 mg per day. Why is Zeaxanthin
and Lutein important? Many studies have suggested that low macular pigment is
associated with a higher risk for age related eye health issues and that it
can be modified via supplementation. The macula contains both lutein and
Zeaxanthin and the eye preferentially accumulates Zeaxanthin in the center of
the macula where the highest density of visual cells reside.
Features:
- Comprehensive Macular Health Formula with Zeaxanthin, Lutein, Omega-3s, and Vitamin D
- Preserve and support vision from age-related eye health issues
- One convenient daily packet
- Doctor recommended
- Manufactured in the U.S.A.